This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourcedmust be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:
This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography articles
Vioxx and the fallout for Merck is one of the main reasons Scolnick is notable. I think it's necessary to revert your deletion. It's not eve so detailed... Nomoskedasticity (talk) 19:15, 24 April 2017 (UTC)Reply
Adding to the consensus: this subject would not be notable without the contested claims. The content should not have been removed; it should be reinstated. comment There are other aspects to his notability: "MIT awards the "Edward M. Scolnick Prize in Neuroscience" in his honor". I would not consider AfD. Maineartists (talk) 19:58, 24 April 2017 (UTC)Reply
Per the WP:BRD process, discussion must occur after editors disagree via reverts. Once a consensus forms here, it will be no problem to have the material added again. However if the main thing Scolnick is notable for is Vioxx, then he doesn't necessarily warrant his own article - you could cover it with ease over at the Vioxx article. Mr Ernie (talk) 20:23, 24 April 2017 (UTC)Reply
I'm not trying to use these as sources for an article, I'm saying that people have wrote these things about him in the context for Vioxx. If people are writing blogs for major newspapers and case studies, that seems like it would strengthen my case for notoriety. Natureium (talk) 00:00, 25 April 2017 (UTC)Reply